Pfizer's prostate cancer drug combination gets US FDA priority review - Reuters
Pfizer's prostate cancer drug combination gets US FDA priority review Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUjI4VHBuUkcxNU9iMkQ4eE5oWmJXblI1S0pRcTZWMWtGY1hqbFhaelVwR0Z4MFFkbHdqTlRULVItTXluWXpMV1hRRmVFd1B2dmNKdDdUZUxNRE15SHp1anJaVVBGdDc0NnV3bS1GaDA5clkzYkM1by1qVi1BdG9hdlJSeV8wUTJxVmpuc2UtTEV3anR2VjZ4bUJ3OVFwUTkyN1l2TVdyYTdmYWJsX1J2MUZPTmVLYzh2R0dHLUZ3?oc=5" target="_blank">Pfizer's prostate cancer drug combination gets US FDA priority review</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PM